You're reading the free version. Trader adds the live tape and alerts.
Start tracking
UTHR Sale Disclosure
Rothblatt Martine A · SEC Form 4 · Filed Nov 6, 2026
Sale
Calculated transaction value
$71.45K
Rothblatt Martine A Chairperson & CEO
UTHR
Transaction date
Nov 5, 2026
Public filing date
Nov 6, 2026
Filing lag
Filed 1 day later
UTHR daily price context
Close on/before transaction
$565.72
Nov 5, 2026
First close after public filing
$582.46
Nov 9, 2026
Return after filing · so far
+2.27%
Through Nov 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 120 shares @ $595.43
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001106578-26-000182
Filing cohort
Transactions in this filing
Showing 9 of 9
Trades
9
Issuers
1
Estimated value
$1.17M
Buys / sales
0 / 9
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| United Therapeutics Corp UTHR | Sale | Nov 5, 2026 | $182.59K |
| United Therapeutics Corp UTHR | Sale | Nov 5, 2026 | $99.99K |
| United Therapeutics Corp UTHR | Sale | Nov 5, 2026 | $336.62K |
| United Therapeutics Corp UTHR | Sale | Nov 5, 2026 | $166.46K |
| United Therapeutics Corp UTHR Current | Sale | Nov 5, 2026 | $71.45K |
| United Therapeutics Corp UTHR | Sale | Nov 5, 2026 | $118.63K |
| United Therapeutics Corp UTHR | Sale | Nov 5, 2026 | $141.67K |
| United Therapeutics Corp UTHR | Sale | Nov 5, 2026 | $6K |
| United Therapeutics Corp UTHR | Sale | Nov 5, 2026 | $48.2K |